Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Predictors of AML Treatment Response

NCT01024127 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT01024127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01024127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Predictors of AML Treatment Response
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
December 31, 2009
Completion date
Not reported
Enrollment
2,500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adult acute myeloid leukemia in remission, childhood acute myeloid leukemia in remission